http://orcid.org/0000-0003-0523-153X
References
- Kaplan M, Muraca M, Hammerman C, Rubaltelli FF, Vilei MT, Vreman HJ, Stevenson DK. Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice. Pediatrics. 2002;110:e47doi:10.1542/peds.110.4.e47.
- Gourley GR. Breast-feeding, neonatal jaundice and kernicterus. Semin Neonatol. 2002;7:135–141. doi:10.1053/siny.2002.0101.
- Shapiro SM, Bhutani VK, Johnson L. Hyperbilirubinemia and kernicterus. Clin Perinatol. 2006;33:387–410. doi:10.1016/j.clp.2006.03.010.
- Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA. 1968;61:748–755. doi:10.1073/pnas.61.2.748.
- Stevenson DK, Vreman HJ, Wong RJ, Contag CH. Carbon monoxide and bilirubin production in neonates. Semin Perinatol. 2001;25:85–93.
- Faul F, Erdfelder E, Buchner A, Lang A-G. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav Res Methods. 2009;41:1149–1160. doi:10.3758/BRM.41.4.1149.
- American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316.
- Stevenson DK, Vreman HJ, Wong RJ. Bilirubin production and the risk of bilirubin neurotoxicity. Semin Perinatol. 2011;35:121–126. doi:10.1053/j.semperi.2011.02.005.
- Bhutani VK, Wong RJ. Bilirubin neurotoxicity in preterm infants: risk and prevention. J Clin Neonatol. 2013;2:61–69. doi:10.4103/2249-4847.116402.
- Bailey DGN, Fuchs H, Hentschel R. Carboxyhemoglobin - the forgotten parameter of neonatal hyperbilirubinemia. J Perinat Med. 2017;45:613–617. doi:10.1515/jpm-2016-0053.
- Kaplan M, Hammerman C, Vreman HJ, Wong RJ, Stevenson DK. Hemolysis and hyperbilirubinemia in antiglobulin positive, direct ABO blood group heterospecific neonates. J Pediatr. 2010;157:772–777. doi:10.1016/j.jpeds.2010.05.024.
- Hammerman C, Vreman HJ, Kaplan M, Stevenson DK. Intravenous immune globulin in neonatal immune hemolytic disease: does it reduce hemolysis? Acta Paediatr. 1996;85:1351–1353.
- Lozar-Krivec J, Bratanic B, Paro-Panjan D. The role of carboxyhemoglobin measured with CO-oximetry in the detection of hemolysis in newborns with ABO alloimmunization. J Matern Fetal Neonatal Med. 2016;29:452–456. doi:10.3109/14767058.2015.1004050.
- Christensen RD, Malleske DT, Lambert DK, Baer VL, Prchal JT, Denson LE, Gerday E, Weaver Lewis KA, Shepherd JG. Measuring end-tidal carbon monoxide of jaundiced neonates in the birth hospital to identify those with hemolysis. Neonatology. 2016;109:1–5. doi:10.1159/000438482.
- Bhutani VK, Wong RJ, Vreman HJ, Stevenson DK. Bilirubin production and hour-specific bilirubin levels. J Perinatol. 2015;35:735–738. doi:10.1038/jp.2015.32.
- Bhutani VK, Srinivas S, Castillo Cuadrado ME, Aby JL, Wong RJ, Stevenson DK. Identification of neonatal haemolysis: an approach to predischarge management of neonatal hyperbilirubinemia. Acta Paediatr. 2016;105:e189–94. doi:10.1111/apa.13341.
- Maisels MJ, Kring E. The contribution of hemolysis to early jaundice in normal newborns. Pediatrics. 2006;118:276–279. doi:10.1542/peds.2005-3042.
- Christensen RD, Lambert DK, Henry E, Yaish HM, Prchal JT. End-tidal carbon monoxide as an indicator of the hemolytic rate. Blood Cells Mol Dis. 2015;54:292–296. doi:10.1016/j.bcmd.2014.11.018.
- Stevenson DK, Fanaroff AA, Maisels MJ, Young BW, Wong RJ, Vreman HJ, MacMahon JR, Yeung CY, Seidman DS, Gale R, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics. 2001;108:31–39. doi:10.1542/peds.108.1.31.